http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106279150-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
| filingDate | 2015-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106279150-B |
| titleOfInvention | Thick cyclics of pyridine and its production and use |
| abstract | The present invention relates to thick cyclics of pyridine and its production and use, and in particular to the compound or pharmaceutically acceptable salt thereof shown in formula I, its pharmaceutical composition, and its for preparing the purposes for the medicine for preventing and/or treating the disease relevant with HIV or illness.The compounds of this invention structure is novel, has higher HIV-resistant activity, and is highly resistant to the drug resistance of inhibition of HIV strain, is a kind of non-nucleoside hiv reverse transcriptase inhibitor with higher application potential. |
| priorityDate | 2015-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 176.